TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.

Joshua Bauml et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.